promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA
methylation is one of the hallmarks of many cancers and methylation changes occur early
during carcinogenesis. Systemic analysis of cfDNA methylation profiles is being developed
for cancer early detection, monitoring for minimal residual disease (MRD), predicting
treatment response and prognosis, and tracing the tissue origin. This review highlights the …